Journal
EMBO JOURNAL
Volume 28, Issue 15, Pages 2244-2258Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2009.159
Keywords
Atg18; autophagy; LC3; myopathy; PI3P phosphatase
Categories
Funding
- NIAID NIH HHS [AI45148, R01 AI042999, R37 AI042999, R01 AI045148] Funding Source: Medline
Ask authors/readers for more resources
The majority of studies on autophagy, a cytoplasmic homeostatis pathway of broad biological and medical significance, have been hitherto focused on the phosphatidylinositol 3-kinases as the regulators of autophagy. Here, we addressed the reverse process driven by phosphoinositide phosphatases and uncovered a key negative regulatory role in autophagy of a phosphatidylinositol 3-phosphate (PI3P) phosphatase Jumpy (MTMR14). Jumpy associated with autophagic isolation membranes and early autophagosomes, defined by the key factor Atg16 necessary for proper localization and development of autophagic organelles. Jumpy orchestrated orderly succession of Atg factors by controlling recruitment to autophagic membranes of the sole mammalian Atg factor that interacts with PI3P, WIPI-1 (Atg18), and by affecting the distribution of Atg9 and LC3, the two Atg factors controlling organization and growth of autophagic membranes. A catalytically inactive Jumpy mutant, R336Q, found in congenital disease centronuclear myopathy, lost the ability to negatively regulate autophagy. This work reports for the first time that initiation of autophagy is controlled not only by the forward reaction of generating PI3P through a lipid kinase but that its levels are controlled by a specific PI3P phosphatase, which when defective can lead to human disease. The EMBO Journal (2009) 28, 2244-2258. doi: 10.1038/emboj.2009.159; Published online 9 July 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available